Is Co Diagnostics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: CODX) stock is to Hold CODX stock.
Out of 1 analyst, 0 (0%) are recommending CODX as a Strong Buy, 0 (0%) are recommending CODX as a Buy, 1 (100%) are recommending CODX as a Hold, 0 (0%) are recommending CODX as a Sell, and 0 (0%) are recommending CODX as a Strong Sell.
What is CODX's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: CODX) forecast ROE is 7.39%, which is considered weak.
What is CODX's Price Target?
According to 1 Wall Street analyst that have issued a 1 year CODX price target, the average CODX price target is $3.00, with the highest CODX stock price forecast at $3.00 and the lowest CODX stock price forecast at $3.00.
The Wall Street analyst predicted that Co Diagnostics's share price could reach $3.00 by May 15, 2024. The average Co Diagnostics stock price prediction forecasts a potential upside of 175.23% from the current CODX share price of $1.09.
What is CODX's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: CODX) forecast ROA is 6.98%, which is lower than the forecast US Diagnostics & Research industry average of 9.45%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.